Asianet NewsableAsianet Newsable
57 results for "

Serum Institute Of India

"
As India achieves major milestone, PM Modi to meet 7 Indian Covid-19 vaccine manufacturers today-dnmAs India achieves major milestone, PM Modi to meet 7 Indian Covid-19 vaccine manufacturers today-dnm

As India achieves major milestone, PM Modi to meet 7 Indian Covid-19 vaccine manufacturers today

The officials confirmed that representatives from seven vaccine makers including Serum Institute of India, Bharat Biotech, Dr Reddy's Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech will be participating in the meeting.
 

Top Stories Oct 23, 2021, 11:35 AM IST

UNGA Abdulla Shahid received 2 doses of Covishield manufactured in India gcwUNGA Abdulla Shahid received 2 doses of Covishield manufactured in India gcw

UN General Assembly prez Abdulla Shahid reveals he received 2 doses of Covishield manufactured in India

The Covishield vaccine, created by the British-Swedish pharmaceutical corporation AstraZeneca, is produced in India by the Serum Institute of India in Pune.

World News Oct 2, 2021, 1:57 PM IST

UK govt Vaccination certificate must meet 'minimum requirements' gcwUK govt Vaccination certificate must meet 'minimum requirements' gcw

UK govt: Vaccination certificate must meet 'minimum requirements', working with India on 'phased approach'

It comes after Covishield, the Oxford/AstraZeneca vaccine made by the Serum Institute of India, was added to an extended UK travel advice on Wednesday.

United Kingdom Sep 23, 2021, 11:38 AM IST

Serum to supply around 22 crore doses of Covishield vaccine to Centre in October gcwSerum to supply around 22 crore doses of Covishield vaccine to Centre in October gcw

Serum to supply around 22 crore doses of Covishield vaccine to Centre in October

Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute of India (SII), stated that the company has increased its Covishield production capacity and will supply 21.90 crore doses to the Government of India and private hospitals in October. 

Top Stories Sep 22, 2021, 3:59 PM IST

UK discussions with India on expanding COVID vaccine certification gcwUK discussions with India on expanding COVID vaccine certification gcw

UK says discussions with India on expanding COVID vaccine certification

According to new regulations, Indian travellers who have received both doses of the Covishield vaccine made by the Serum Institute of India (SII) would be considered unvaccinated and must undergo self-isolation for ten days.

United Kingdom Sep 21, 2021, 9:35 AM IST

Shashi Tharoor reacts pulls out of UK event over new COVID travel policy for Indians gcwShashi Tharoor reacts pulls out of UK event over new COVID travel policy for Indians gcw

'Offensive': Shashi Tharoor pulls out of UK event over new COVID travel policy for Indians

Fully vaccinated Indians who got Covishield, the Oxford/AstraZeneca vaccine manufactured by the Serum Institute of India, will still be subjected to a pre-departure PCR test and further testing upon arrival in the UK.

Top Stories Sep 20, 2021, 5:11 PM IST

Serum Institute to begin production of Sputnik V vaccine in September-dnmSerum Institute to begin production of Sputnik V vaccine in September-dnm

Serum Institute to begin production of Sputnik V vaccine in September

Russia's Sputnik V coronavirus vaccine developers and Serum Institute of India (SII) have announced plans to start producing the vaccine in India in September.

Top Stories Jul 13, 2021, 2:19 PM IST

Zydus Cadila applies for emergency use authorisation of its COVID-19 vaccine-dnmZydus Cadila applies for emergency use authorisation of its COVID-19 vaccine-dnm

Zydus Cadila applies for emergency use authorisation of its COVID-19 vaccine

An approval for Zydus’ vaccine, ZyCoV-D, would make it the fifth vaccine authorized for use in India, after Moderna, AstraZeneca and partner Serum Institute of India’s Covishield, Bharat Biotech’s Covaxin and Sputnik V developed by Russia’s Gamaleya Institute.

Top Stories Jul 1, 2021, 9:53 AM IST

Serum Institute to start clinical trials of Novavax COVID vaccine for children in July: Report-dnmSerum Institute to start clinical trials of Novavax COVID vaccine for children in July: Report-dnm

Serum Institute to start clinical trials of Novavax COVID vaccine for children in July: Report

The US-based biotechnology company Novavax has tied up with the Serum Institute of India (SII) to manufacture its Covid-19 vaccine, namely Covovax.

Top Stories Jun 17, 2021, 6:14 PM IST

Novavax claims 90.4% efficacy against Covid-19, SII to manufacture it as Covavax-VPNNovavax claims 90.4% efficacy against Covid-19, SII to manufacture it as Covavax-VPN

Novavax claims 90.4% efficacy against Covid-19, SII to manufacture it as Covavax

Novavax, which is reported to be 90.4% effective against Coronavirus, will be manufactured in India as Covovax by the Serum Institute of India and it is estimated that the vaccine shots will be available by September this year.

Top Stories Jun 15, 2021, 8:58 AM IST

Centre sets record straight, denies not placing fresh order for vaccines-VPNCentre sets record straight, denies not placing fresh order for vaccines-VPN

Centre sets record straight, denies not placing fresh order for vaccines

The reports, which surfaced on Monday, claimed that the last order Centre placed was in March 2021 for 100 million doses of Serum Institute of India's Covishield and 20 million doses of Bharat Biotech's Covaxin.

Top Stories May 3, 2021, 3:31 PM IST

Y category security for Adar Poonawalla MHA issues order-VPNY category security for Adar Poonawalla MHA issues order-VPN

Y category security for Adar Poonawalla; MHA issues order

The Central Reserve Police Force will provide security to Serum Institute of India CEO and owner Adar Poonawalla.

Top Stories Apr 28, 2021, 8:03 PM IST

Serum Institute philanthropic gesture Covishield to be Rs 100 cheaper-VPNSerum Institute philanthropic gesture Covishield to be Rs 100 cheaper-VPN

Serum Institute's 'philanthropic gesture': Covishield to be Rs 100 cheaper

Making the announcement on Twitter, Adar Poonawalla said: "As a philanthropic gesture on behalf of Serum Institute of India, I hereby reduce the price to the states from Rs 400 to Rs 300 per dose, effective immediately."

Coronavirus Apr 28, 2021, 6:11 PM IST

About 0.04% people tested positive after second dose of Covaxin, 0.03% for Covishield: Government-dnmAbout 0.04% people tested positive after second dose of Covaxin, 0.03% for Covishield: Government-dnm

About 0.04% people tested positive after second dose of Covaxin, 0.03% for Covishield: Government

India has currently given Emergency Use Authorisation to three vaccine candidates: indigenously manufactured vaccines (Serum Institute of India and Bharat Biotech), and a third vaccine (Sputnik) that while presently manufactured abroad will eventually be manufactured in India.
 

Top Stories Apr 21, 2021, 5:16 PM IST

AstraZeneca serves legal notice to Serum Institute over delays in supplying COVID-19 vaccine-dnmAstraZeneca serves legal notice to Serum Institute over delays in supplying COVID-19 vaccine-dnm

AstraZeneca serves legal notice to Serum Institute over delays in supplying COVID-19 vaccine

Adar Poonawalla, the Chief Executive Officer of Serum Institute of India on Tuesday said that pharmaceutical company AstraZeneca has sent Serum Institute a legal notice over delays in supplying the vaccine.
 

Top Stories Apr 7, 2021, 6:11 PM IST